Who owns Renasys?
Renasys is owned by Smith+Nephew (the United Kingdom, LSE: SN).[1]
Evidence: Smith & Nephew plc Annual Report on Form 20-F filed 2026-03-16, SEC EDGAR, 16 March 2026. Verified from filings; last checked .
Key facts
- Current owner
- Smith & Nephew plc verified
- Owner HQ
- 🇬🇧 United Kingdom, Watford
- Origin
- 🇬🇧 United Kingdom
- Category
- Consumer health › First aid & wound care › Bandages & wound care
- Parent ticker
- LSE: SN
- Last verified
- · 1 sources
About Renasys
Renasys is the traditional negative pressure wound therapy system in the Smith+Nephew Advanced Wound Management range, named in the company's 2025 results announcement alongside the single-use Pico system. The announcement describes Pico as the single-use alternative in the same negative pressure wound therapy family.
Ownership timeline of Renasys
- Current owner Smith+Nephew [1] verified
Where Renasys sits in Smith+Nephew
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Smith+Nephew ownership tree →
See the full Smith+Nephew brand portfolio (3) →
Other brands owned by Smith+Nephew
Smith+Nephew controls 3 brands on Brandtree, 3 of them in consumer health.
Also in consumer health
Other brands in bandages & wound care, and who owns them
The 20 brands in bandages & wound care on Brandtree belong to 12 owners. The largest is HARTMANN, with 4; Smith+Nephew has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| Atrauman | HARTMANN | 🇩🇪 Germany |
| Biatain | Coloplast | 🇩🇰 Denmark |
| Aquacel | Convatec | 🇬🇧 United Kingdom |
| Nexcare | 3M | 🇺🇸 United States |
| Hansaplast | Beiersdorf | 🇩🇪 Germany |
| Pantinol Plus | Birzeit Pharmaceutical | 🇵🇸 Palestine |
| Makiron | Daiichi Sankyo Healthcare | 🇯🇵 Japan |
| JOBST | Essity | 🇸🇪 Sweden |
About the owner: Smith+Nephew
Smith+Nephew is a publicly listed company headquartered in Watford, United Kingdom, founded in 1856. Brandtree records 3 brands under its control, and it is listed as LSE: SN.
Smith+Nephew is a UK-headquartered medical technology company based in Watford that files an annual Form 20-F with the SEC. Its 2025 report describes a 170-year history and revenue of $6,164 million, of which Advanced Wound Management was $1,793 million; the rest is mainly orthopaedics and sports medicine and ENT, which are outside this site's consumer categories.
Smith+Nephew: full profile, brands and acquisition history →
🇬🇧 Renasys and other British brands
Brandtree records a controlling owner for 543 brands that began in the United Kingdom. 282 of them (52%) are now controlled by a company headquartered in another country; Renasys is not one of them.
Frequently asked questions
Who is the parent company of Renasys?
The parent company of Renasys is Smith+Nephew, a publicly listed company headquartered in the United Kingdom.
Is Renasys British?
Yes. Renasys originated in the United Kingdom and its owner, Smith+Nephew, is also headquartered in the United Kingdom.
Is Renasys still owned by Smith+Nephew?
Yes. As of 3 October 2026, Renasys is still owned by Smith+Nephew. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Smith & Nephew plc Annual Report on Form 20-F filed 2026-03-16 — SEC EDGAR, SEC Form 20-F, published 16 March 2026; retrieved 3 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.